Muscle strength and mass in inflammatory bowel disease
Part of Brain & nervous system, Digestive system clinical trials.
This study looks at muscle strength and muscle mass in people with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. It aims to understand how IBD affects muscles, which can help improve patient care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with inflammatory bowel disease (Crohn's disease or ulcerative colitis)
- You can give your written permission to take part
- You are able to have an ultrasound of your muscles and a handgrip strength test
- You have had a CT scan of your abdomen in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses ultrasound to measure how much damage Crohn's disease has caused in your intestines, which may help doctors track the disease without repeated scans or procedures.
This trial tests if a small, hand-held ultrasound device can detect inflammation in the bowel caused by Crohn's disease. It may offer a simpler, more accessible way to monitor the disease.
This trial compares two types of MRI scans to see how well they detect inflammation in the small intestine of people with Crohn's disease. It aims to find the best way to assess disease activity without invasive procedures.
This trial tests whether a specific set of abdominal exercises can help reduce inflammation and improve symptoms in people with Crohn's disease. You'll do the exercises at home daily, and the study will track your results over time to see if it's a helpful addition to your usual care.
This study uses an intestinal ultrasound (a safe, painless scan) to check how well Crohn's disease is controlled. It may help doctors see inflammation without more invasive tests.
This study looks at body composition (fat and muscle) in people with Crohn's disease or ulcerative colitis. It tests if a new way to monitor body changes can help guide treatment with biologic or JAK inhibitor medicines.
Hear when a new Crohn Disease (CD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.